Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor

INTRODUCTION: Metabolic syndrome (MetS) is a global healthcare burden associated with an increased risk of atherosclerosis (ATH). It is well understood that atherogenesis involves the complexity of inflammation, endothelial dysfunction, and oxidative stress. However, the relationship between atherog...

Full description

Bibliographic Details
Published in:IIUM Medical Journal Malaysia
Main Author: Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
Format: Article
Language:English
Published: International Islamic University Malaysia 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164986563&doi=10.31436%2fimjm.v22i3.2297&partnerID=40&md5=03a3c9b5c6040c62f6fc33abd20d9adc
id 2-s2.0-85164986563
spelling 2-s2.0-85164986563
Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
2023
IIUM Medical Journal Malaysia
22
3
10.31436/imjm.v22i3.2297
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164986563&doi=10.31436%2fimjm.v22i3.2297&partnerID=40&md5=03a3c9b5c6040c62f6fc33abd20d9adc
INTRODUCTION: Metabolic syndrome (MetS) is a global healthcare burden associated with an increased risk of atherosclerosis (ATH). It is well understood that atherogenesis involves the complexity of inflammation, endothelial dysfunction, and oxidative stress. However, the relationship between atherogenic lipoproteins [small dense low-density lipoproteins (sdLDL)] and oxidative stress biomarkers [isoprostane (ISP)] among those with MetS has not been well established, which this study aims to understand. MATERIALS & METHODS: This cross-sectional study involved 67 MetS and 43 non-MetS subjects diagnosed by JIS criteria 2009. Demographic details and anthropometric measurements were recorded. Blood samples were collected to analyse direct LDL, sdLDL-c, and ISP. RESULTS: Mean serum sdLDL-c were significantly higher in MetS than non-MetS (1.14+0.44 mmol/L vs. 0.87±0.38 mmol/L, respectively, p=0.005). Similarly, mean serum ISP concentration was higher among MetS than non-MetS (884.40+602.69 ng/L vs. 657.89±616.42 ng/L, respectively, p=0.054). sdLDL-c was positively correlated with triglyceride (TG) in MetS (Spearman 0.552, p<.001), while HDL-c was positively correlated with sdLDL-c among non-MetS (Spearman 0.400, p<.005). CONCLUSION: This study emphasises the relationship between sdLDL-c and TG in MetS, emphasising the importance of closely monitoring and managing TG in this cohort to reduce the risk of ATH. It was noted that HDL-c showed a positive correlation with sdLDL-c among non-MetS. This discordant finding suggests that HDL-c may not be causally associated with cardiovascular benefits and that HDL-c subfractions may be a better approach to determining the cardioprotective effects of HDL-c. © 2023, IIUM Medical Journal Malaysia. All Rights Reserved.
International Islamic University Malaysia
27352285
English
Article
All Open Access; Bronze Open Access
author Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
spellingShingle Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
author_facet Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
author_sort Razali N.A.A.; Rahman T.A.; Ismail Z.; Kadir S.H.S.A.; Razak S.A.; Raja Shariff R.E.; Shibraumalisi N.A.
title Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
title_short Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
title_full Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
title_fullStr Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
title_full_unstemmed Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
title_sort Correlations of Estimated Serum Small Dense Low-Density Lipoprotein and Isoprostane with Metabolic Syndrome Criteria between Metabolic Syndrome and Non-Metabolic Syndrome Subjects in Selangor
publishDate 2023
container_title IIUM Medical Journal Malaysia
container_volume 22
container_issue 3
doi_str_mv 10.31436/imjm.v22i3.2297
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85164986563&doi=10.31436%2fimjm.v22i3.2297&partnerID=40&md5=03a3c9b5c6040c62f6fc33abd20d9adc
description INTRODUCTION: Metabolic syndrome (MetS) is a global healthcare burden associated with an increased risk of atherosclerosis (ATH). It is well understood that atherogenesis involves the complexity of inflammation, endothelial dysfunction, and oxidative stress. However, the relationship between atherogenic lipoproteins [small dense low-density lipoproteins (sdLDL)] and oxidative stress biomarkers [isoprostane (ISP)] among those with MetS has not been well established, which this study aims to understand. MATERIALS & METHODS: This cross-sectional study involved 67 MetS and 43 non-MetS subjects diagnosed by JIS criteria 2009. Demographic details and anthropometric measurements were recorded. Blood samples were collected to analyse direct LDL, sdLDL-c, and ISP. RESULTS: Mean serum sdLDL-c were significantly higher in MetS than non-MetS (1.14+0.44 mmol/L vs. 0.87±0.38 mmol/L, respectively, p=0.005). Similarly, mean serum ISP concentration was higher among MetS than non-MetS (884.40+602.69 ng/L vs. 657.89±616.42 ng/L, respectively, p=0.054). sdLDL-c was positively correlated with triglyceride (TG) in MetS (Spearman 0.552, p<.001), while HDL-c was positively correlated with sdLDL-c among non-MetS (Spearman 0.400, p<.005). CONCLUSION: This study emphasises the relationship between sdLDL-c and TG in MetS, emphasising the importance of closely monitoring and managing TG in this cohort to reduce the risk of ATH. It was noted that HDL-c showed a positive correlation with sdLDL-c among non-MetS. This discordant finding suggests that HDL-c may not be causally associated with cardiovascular benefits and that HDL-c subfractions may be a better approach to determining the cardioprotective effects of HDL-c. © 2023, IIUM Medical Journal Malaysia. All Rights Reserved.
publisher International Islamic University Malaysia
issn 27352285
language English
format Article
accesstype All Open Access; Bronze Open Access
record_format scopus
collection Scopus
_version_ 1809678477190758400